Uterine fibroids: current perspectives
AT Khan, M Shehmar, JK Gupta - International journal of women's …, 2014 - Taylor & Francis
Uterine fibroids are a major cause of morbidity in women of a reproductive age (and
sometimes even after menopause). There are several factors that are attributed to underlie …
sometimes even after menopause). There are several factors that are attributed to underlie …
Preoperative medical therapy before surgery for uterine fibroids
A Lethaby, L Puscasiu… - Cochrane Database of …, 2017 - cochranelibrary.com
Background Uterine fibroids occur in up to 40% of women aged over 35 years. Some are
asymptomatic, but up to 50% cause symptoms that warrant therapy. Symptoms include …
asymptomatic, but up to 50% cause symptoms that warrant therapy. Symptoms include …
The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis
EA Pritts, DJ Vanness, JS Berek, W Parker… - Gynecological …, 2015 - Springer
There is a concern regarding the risk of occult leiomyosarcomas found at surgery for
presumed benign fibroids. We sought to produce a comprehensive review of published data …
presumed benign fibroids. We sought to produce a comprehensive review of published data …
Medical treatment of uterine leiomyoma
M Sabry, A Al-Hendy - Reproductive sciences, 2012 - journals.sagepub.com
Uterine leiomyomas (also called myomata or fibroids) are the most common gynecologic
tumors in the United States. The prevalence of leiomyomas is at least 3 to 4 times higher …
tumors in the United States. The prevalence of leiomyomas is at least 3 to 4 times higher …
Innovative oral treatments of uterine leiomyoma
M Sabry, A Al-Hendy - Obstetrics and gynecology international, 2012 - Wiley Online Library
Uterine fibroids (leiomyoma), the benign tumors of the uterine wall, are very common cause
of morbidity in reproductive age women usually in the form of excessive vaginal bleeding …
of morbidity in reproductive age women usually in the form of excessive vaginal bleeding …
Medical therapies for uterine fibroids–a systematic review and network meta-analysis of randomised controlled trials
KS Gurusamy, J Vaughan, IS Fraser, LMJ Best… - PLoS …, 2016 - journals.plos.org
Background Uterine fibroids are common, often symptomatic and a third of women need
repeated time off work. Consequently 25% to 50% of women with fibroids receive surgical …
repeated time off work. Consequently 25% to 50% of women with fibroids receive surgical …
Natural uptake of anti-oomycetes Trichoderma produced secondary metabolites from pearl millet seedlings–A new mechanism of biological control of downy mildew …
The present study aims to analyze the pearl millet (PM) seedlings ability to uptake anti-
oomycetes secondary metabolites (SMs) produced by Trichoderma and their subsequent …
oomycetes secondary metabolites (SMs) produced by Trichoderma and their subsequent …
Pre-treatment with GnRHa or ulipristal acetate prior to laparoscopic and laparotomic myomectomy: A systematic review and meta-analysis
I De Milliano, M Twisk, JC Ket, JA Huirne… - PLoS …, 2017 - journals.plos.org
Background Myomectomy has potential risks of complications. To reduce these risks,
medical pre-treatment can be applied to reduce fibroid size and thereby potentially decrease …
medical pre-treatment can be applied to reduce fibroid size and thereby potentially decrease …
The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids: a meta-analysis
Y Zhang, L Sun, Y Guo, J Cheng, Y Wang… - Obstetrical & …, 2014 - journals.lww.com
Aim The objectives of this study were to evaluate the efficacy of gonadotropin-releasing
hormone agonist (GnRHa) treatment before surgery for women with uterine fibroids and to …
hormone agonist (GnRHa) treatment before surgery for women with uterine fibroids and to …
Expanded somatic mutation spectrum of MED12 gene in uterine leiomyomas of Saudi Arabian women
GMA Ajabnoor, NA Mohammed, B Banaganapalli… - Frontiers in …, 2018 - frontiersin.org
MED12, a subunit of mediator complex genes is known to harbor genetic mutations,(mostly
in exon 2), causal to the genesis of uterine leiomyomas among Caucasian, African …
in exon 2), causal to the genesis of uterine leiomyomas among Caucasian, African …